文献速递造血干细胞移植与细胞治疗贫血与红细胞疾病

纤溶酶介导的纤维蛋白溶解是5-FU诱导骨髓消融后造血恢复所必需的

Plasmin-mediated fibrinolysis is required for hematopoietic recovery after 5-FU-induced myeloablation.
PubMed 文献 · Blood Adv · 2026-01-01

该研究在小鼠模型中采用5-氟尿嘧啶诱导骨髓消融,发现骨髓微环境出现均匀的血管外纤维蛋白沉积,纤溶酶原缺陷小鼠因纤维蛋白持续沉积导致造血恢复失败。遗传或药物清除纤维蛋白原可恢复造血,且纤维蛋白通过髓系整合素αMβ2延迟恢复;人骨髓损伤/衰竭状态也可见类似纤维蛋白富集微环境。

要点

  • 骨髓消融后骨髓微环境出现血管外纤维蛋白沉积,纤溶系统对清除纤维蛋白至关重要。
  • 纤溶酶原缺陷小鼠因纤维蛋白持续沉积而造血恢复失败,清除纤维蛋白原可恢复。
  • 纤维蛋白通过髓系整合素αMβ2介导纤溶缺陷导致的造血恢复延迟。

核心结论

  • 纤溶酶介导的纤维蛋白溶解是5-FU诱导骨髓消融后造血恢复所必需的。
  • 纤溶缺陷通过纤维蛋白与αMβ2整合素结合导致造血恢复延迟。

研究设计与样本

  • 研究采用5-氟尿嘧啶介导骨髓消融的小鼠模型。
  • 利用纤溶酶原缺陷小鼠及遗传和药理学纤维蛋白原清除方法。
  • 并观察了人骨髓损伤和衰竭状态下的骨髓微环境。

主要发现

  • 骨髓消融后骨髓微环境出现均匀的血管外纤维蛋白沉积。
  • 纤溶酶原缺陷小鼠纤维蛋白持续沉积导致造血恢复失败。
  • 消融后遗传或药理学清除纤维蛋白原可恢复造血。
  • 纤溶缺陷通过纤维蛋白与髓系整合素αMβ2结合导致造血恢复延迟。
  • 人骨髓损伤和衰竭状态也可见纤维蛋白富集的骨髓微环境。

临床怎么用

  • 提示靶向纤溶-纤维蛋白通路可能促进骨髓消融后造血恢复。

局限性

  • 主要证据来自小鼠模型,人体数据为观察性骨髓微环境发现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Hematopoietic recovery after myeloablation plays a critical role in the survival of patients who receive chemotherapy or hematopoietic stem cell transplantation. Understanding the mechanisms underlying hematopoiesis helps identify the molecular and/or cellular determinants that could be targeted to enhance hematopoietic recovery. Although several mechanisms by which the plasminogen (Plg) activation system promotes hematopoietic recovery after myelosuppression have been reported, the specific role fibrinolysis plays in hematopoietic recovery is unclear. The current study employs 5-fluorouracil-mediated myeloablation in murine models and provides a clear demonstration of uniform extravascular fibrin deposits in the bone marrow (BM) niche upon myeloablation. Persistent fibrin deposits in Plg-deficient mice lead to failure of hematopoietic recovery. Genetic and pharmacological depletion of fibrinogen after myeloablation restored hematopoietic recovery, revealing the critical role fibrin plays in this process. Moreover, defective fibrinolysis led to delayed hematopoietic recovery via a mechanism that involves fibrin engagement with the major myeloid integrin αMβ2. Importantly, similar fibrin-rich marrow niches were also observed in human BM injury and failure states. The study identifies a novel molecular pathway that could be therapeutically targeted to enhance hematopoietic recovery after myeloablation.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Nguyen TP, Jiang YG, Ogan BM, et al. Plasmin-mediated fibrinolysis is required for hematopoietic recovery after 5-FU-induced myeloablation. Blood Adv. 2026. PMID: 42314039. doi:10.1182/bloodadvances.2025019416

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。